NCT04963283 2026-02-10Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal CancerUniversity of Colorado, DenverPhase 2 Active not recruiting48 enrolled
NCT03170960 2025-08-17Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsExelixisPhase 1 Active not recruiting914 enrolled